non-small cell lung cancer
Conditions
Interventions
Gold Standard:digital PCR
in 
peripheral 
blood 
of 
patients 
with 
cell 
lung 
cancer 
(NSCLC) 
was 
qualitatively 
by 
combined 
Sponsors
Beijing Chest Hospital affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: (1) Over 18 years of age; (2) One of the following can be satisfied: 1) Diagnosed with non-small cell lung cancer (NSCLC) in middle-late stage (i.e. the pathological staging of III ~ IV) patients; 2) Interference group samples clinically diagnosed as pulmonary benign tumor, small cell lung cancer, etc.; (3) 14-20ml peripheral blood samples can be collected, and corresponding samples should be provided for patients undergoing homology study FFPE samples;(Synchronous definition: for the surgical tissue, blood collection is required within one week before the operation; for the puncture tissue, the time difference between the collection of tissue and peripheral blood is required within one week). (4) Sign informed consent voluntarily.
Exclusion criteria
Exclusion criteria: (1) Patients with unqualified quality control of nucleic acid samples after extraction; (2) patients diagnosed with the second primary malignant tumor; (3) Patients who have received previous transplantation operations; (4) Patients who have received allogeneic blood transfusion or immunotherapy that may introduce foreign DNA or other patients who may introduce foreign DNA within one year; (5) Poor compliance or conditions that the researcher considers inappropriate to be included in the study; (6) Incomplete samples of case information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gene mutation;Consistency; | — |
Countries
China
Contacts
Public ContactChe Nanying
Beijing Chest Hospital affiliated to Capital Medical University
Outcome results
None listed